MedPath

Biologische tumorkenmerken voorspellend voor de respons op chemoradiotherapie bij slokdarmkanker

Conditions
non-metastastatic esophageal cancerniet uitgezaaid slokdarmkanker
Registration Number
NL-OMON23044
Lead Sponsor
Medisch Centrum Leeuwarden. investigator initiated
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
85
Inclusion Criteria

All patients referred to MCL with pathologically proven carcinoma of the esophagus and without distant metastases will be asked to participate

Exclusion Criteria

none

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main study parameters are differences in kinetic profile and/or genetic profile between patients with and without a pathologic complete response after chemo radiation.
Secondary Outcome Measures
NameTimeMethod
The association of the created predictive profile and relapse/survival outcome parameters
© Copyright 2025. All Rights Reserved by MedPath